 CohBar, Inc. CWBR a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, is hosting its Annual Shareholder Meeting and Investor Update on June 16, 2020. On the same day, CohBar will also provide a company update for investors via conference call and accompanying slide presentation. 